Progress in the development of TRPV1 small-molecule antagonists: Novel Strategies for pain management
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference182 articles.
1. Novel approaches to persistent pain therapy;Sisignano;Trends Pharmacol. Sci.,2019
2. Rethinking chronic pain;The;Lancet,2021
3. Chronic pain: an update on burden, best practices, and new advances;Cohen;Lancet,2021
4. Neuropathic pain: mechanism-based therapeutics;Bannister;Annu. Rev. Pharmacol. Toxicol.,2020
5. Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016;Dahlhamer;MMWR Morb. Mortal. Wkly. Rep.,2018
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management;Life Sciences;2024-10
2. The Endocannabinoid Peptide RVD-Hemopressin Is a TRPV1 Channel Blocker;Biomolecules;2024-09-08
3. TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates;Progress in Neurobiology;2024-09
4. Discovery of N-(1,4-Benzoxazin-3-one) urea analogs as Mode-Selective TRPV1 antagonists;Bioorganic & Medicinal Chemistry Letters;2024-07
5. Association between Variants of the TRPV1 Gene and Body Composition in Sub-Saharan Africans;Genes;2024-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3